20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T6446 | Clevudine | L-FMAU,Levovir | HBV , DNA/RNA Synthesis |
Clevudine (Levovir) is a synthetic pyrimidine analogue with activity against hepatitis B virus (HBV). Intracellularly, clevudine is phosphorylated to its active metabolites, clevudine monophosphate and triphosphate. The ... | |||
T21474 | Navuridine | AZddU,CS 87,CS-87,AzUrd,3'-Azido-2',3'-dideoxyuridine,AZdU | HIV Protease |
Navuridine (AZdU) is an oral active inhibitor of HIV reverse transcriptase with a relatively short half-life. | |||
T1223 | Ceftriaxone sodium hydrate | Ceftriaxone Sodium Trihydrate,Ceftriaxone disodium hemiheptahydrate,Ceftriaxone sodium | Others , Antibacterial , Antibiotic |
Ceftriaxone sodium hydrate is a broad-spectrum cephalosporin antibiotic with a very long half-life and high penetrability to meninges, eyes and inner ears. | |||
T67905 | GS-829845 | JAK , Drug Metabolite | |
GS-829845 is a JAK1 inhibitor, the main component of the active metabolite of Filgotinib, which is approximately 10-fold less potent and has a longer half-life than the parent. | |||
T33941 | PF-03635659 | PF03635659,PF 03635659 | AChR |
PF-03635659 is a potent and long dissociative half-life muscarinic M3 antagonist (Ki: 0.2 nM) that shows potential for the treatment of chronic obstructive pulmonary disease (COPD). | |||
T10392 | Aspoxicillin | Anti-infection , Antibacterial | |
Aspoxicillin, a broad-spectrum antimicrobial agent, demonstrates efficacy against 68 isolates of Actinobacillus pleuropneumoniae, with a minimum inhibitory concentration (MIC90) of <= 0.05 μg/ml. It exhibits a prolonged ... | |||
T3967 | Exendin-4 | Exenatide,Exenatide Acetate | Glucagon Receptor |
Exendin-4 (Exenatide) is a glucagon-like peptide-1 receptor (GLP-1) agonist (IC50: 3.22 nM). Exenatide is a 39 amino acid peptide. Compared to GLP-1, exenatide has a longer half-life of 2.4 hours. | |||
T71708 | Minamestane | Aromatase | |
Minamestane is a novel irreversible aromatase inhibitor.Minamestane induces time-dependent inhibition of human placental aromatase with a half-life of 4 minutes and a K of 59 nM.Minamestane has antitumor activity. | |||
T1410 | Torsemide | AC-4464,JDL-464,Torasemide | Na-K-Cl cotransporter |
Torsemide (AC-4464) is an anilinopyridine sulfonylurea belonging to the class of loop diuretics. Torsemide has a prolonged duration of action compared to other loop diuretics, is extensively protein bound in plasma and h... | |||
T4814 | (R)-5-Oxopyrrolidine-2-carboxylic acid | D-Pyroglutamic acid,(R)-(+)-2-Pyrrolidone-5-carboxylic acid | Others , Endogenous Metabolite |
(R)-5-Oxopyrrolidine-2-carboxylic acid (D-Pyroglutamic acid) is a cyclic derivative of glutamic acid, physiologically present in mammalian tissues. It has been shown that PCA releases GABA from the cerebral cortex and di... | |||
T0195 | Secnidazole | RP-14539,PM-185184 | Antibiotic , Parasite |
Secnidazole (PM-185184) is a second-generation 5-nitroimidazole antimicrobial that is structurally related to other 5-nitroimidazoles including [DB00916] and [DB00911], but displays improved oral absorption and longer te... | |||
T15300 | Fluorofenidone | AKF-PD | Others |
Fluorofenidone (AKF-PD) attenuates the progression of renal interstitial fibrosis partly by suppressing NADPH oxidase and extracellular matrix (ECM) deposition via the PI3K/Akt signalling pathway. Fluorofenidone is an an... | |||
T4940 | 3-Methylhistamine dihydrochloride | Others , Endogenous Metabolite | |
N tau-methylhistamine is one of the histamine metabolites. N tau-methylhistamine in plasma and urine is a good parameter for histamine release, and the determination of this histamine metabolite is generally less hampere... | |||
T60919 | SARS-CoV-2-IN-13 | SARS-CoV | |
SARS-CoV-2-IN-13 (compound 5) is an analogue of niclosamide. SARS-CoV-2-IN-13 is more stable than niclosamide in human plasma and liver S9 enzymes assay. SARS-CoV-2-IN-13 can improve bioavailability and half-life when ad... | |||
T60538 | SARS-CoV-2-IN-14 | 3',5-Dichlorosalicylanilide | SARS-CoV |
SARS-CoV-2-IN-14 is a potent and oral inhibitor of SARS-CoV-2 (IC50:0.39 μM), which is an analogue of niclosamide. SARS-CoV-2-IN-14 was more stable than niclosamide in the determination of human plasma and liver S9 enzym... | |||
TP1895L1 | KYL acetate(676657-00-4 free base) | Ephrin Receptor | |
KYL acetate is an EphA4 receptor tyrosine kinase inhibitor (Kd = 0.8 μM); inhibits EphA4-EphrinA5 interactions (IC50 = 6.34 μM). Prevents AβO induced synaptic damage, dendritic spine loss and prevents the blocking of LTP... | |||
T15117 | Didesmethyl cariprazine | Dopamine Receptor , 5-HT Receptor | |
Didesmethyl cariprazine, a metabolite of Cariprazine, is the major cyclic active part. Didesmethyl cariprazine has a long half-life of 1-3 weeks. Cariprazine is a potent D3 preference D3/D2 receptor partial agonist of do... | |||
T3716 | Rolapitant | SCH619734 | Neurokinin receptor |
Rolapitant (SCH619734) Hydrochloride is the hydrochloride salt form of rolapitant, an orally bioavailable, centrally-acting, selective, neurokinin 1 receptor (NK1-receptor) antagonist with potential antiemetic activity. ... | |||
T2671 | Regadenoson | CVT-3146,Lexiscan | Adenosine Receptor |
Regadenoson (CVT-3146) is an adenosine derivative and selective A2A adenosine receptor agonist with coronary vasodilating activity. Upon administration, regadenoson selectively binds to and activates the A2A adenosine re... | |||
T8947 | Dasiglucagon acetate | dasiglucagon acetate(1544300-84-6 free base) | Others |
Dasiglucagon acetate is a novel glucagon analog for diabetic hypoglycemia therapy. Dasiglucagon acetate has demonstrated established solubility and stability in an aqueous formulation. Pharmacokinetics studies have shown... |